ATYR PHARMA INC (LIFE)
US0021202025 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | -100.00% | 10.386M | 353K -96.60% | 338.64K -4.07% | 9.508M 2,707.70% | 93.399M 882.32% | 179M 91.65% | 386.67M 116.02% | 527.66M 36.46% | 753.26M 42.75% | 990.03M 31.43% | |
| EBITDA YoY % growth | -33.54M -118.64% | -46.172M -37.66% | -54.327M -17.66% | -73.134M -34.62% | -74.868M -2.37% | 51.408M 168.66% | 61.251M 19.15% | 278.15M 354.12% | 171.26M -38.43% | 281.52M 64.38% | 395.76M 40.58% | |
| EBIT YoY % growth | -34.015M -113.80% | -46.404M -36.42% | -54.919M -18.35% | -66.588M -21.25% | -59.287M 10.96% | -2.257M 96.19% | 54.173M 2,500.22% | 228.29M 321.41% | 352.81M 54.54% | 549.58M 55.77% | 799.19M 45.42% | |
| Operating Margin | N/A | -446.79% | -15,557.79% | -19,663.25% | -623.55% | -2.42% | 30.26% | 59.04% | 66.86% | 72.96% | 80.72% | |
| EPS YoY % growth | -1.88 -18.24% | -1.60 14.89% | -0.96 40.00% | -0.94 2.52% | -0.78 16.89% | 0.01 101.64% | 0.67 5,148.00% | 2.39 257.32% | 4.01 67.88% | 6.41 59.72% | 8.69 35.56% |
All data in USD
| Q2 / 24 | Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.23 -6.64% | -0.23 -16.03% | -0.26 -2.82% | -0.26 -10.87% | -0.27 -13.04% | -0.27 -14.29% | -0.27 -3.17% |
| Revenue Q2Q % growth | 25.5K | 25.5K -92.78% | 20.4K | -100.00% | -100.00% | -100.00% | -100.00% |
| EBITDA Q2Q % growth | -17.952M -34.77% | -18.666M -53.03% | -19.584M -27.44% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -15.967M -17.75% | -15.627M -23.87% | -18.001M -12.80% | -17.607M -5.84% | -18.509M -15.92% | -18.556M -18.74% | -18.849M -4.71% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2024 Q2Q % growth | -0.23 20.69% | -0.24 | 0.01 | 4.45% |
| Q4 2023 Q2Q % growth | -0.25 3.85% | -0.24 | -0.01 | -2.98% |
| Q3 2023 Q2Q % growth | -0.20 56.52% | -0.23 | 0.03 | 13.24% |
| Q2 2023 Q2Q % growth | -0.22 50.00% | -0.28 | 0.06 | 22.57% |
| Q1 2023 Q2Q % growth | -0.29 34.09% | -0.41 | 0.12 | 28.62% |
| Q4 2022 Q2Q % growth | -0.26 16.13% | -0.49 | 0.23 | 46.90% |
| Q3 2022 Q2Q % growth | -0.46 -9.52% | -0.47 | 0.01 | 2.32% |
| Q2 2022 Q2Q % growth | -0.44 31.25% | -0.39 | -0.05 | -12.92% |
| Q1 2022 Q2Q % growth | -0.44 13.73% | -0.34 | -0.10 | -30.06% |
| Q4 2021 Q2Q % growth | -0.31 34.04% | -0.29 | -0.02 | -7.27% |
| Q3 2021 Q2Q % growth | -0.42 38.24% | -0.61 | 0.19 | 30.88% |
| Q2 2021 Q2Q % growth | -0.64 7.25% | -0.52 | -0.12 | -23.51% |
| Q1 2021 Q2Q % growth | -0.51 -304.00% | -0.32 | -0.19 | -57.48% |
| Q4 2020 Q2Q % growth | -0.47 69.48% | -0.84 | 0.37 | 44.03% |
| Q3 2020 Q2Q % growth | -0.68 53.74% | -0.76 | 0.08 | 10.31% |
| Q2 2020 Q2Q % growth | -0.69 61.67% | -0.74 | 0.05 | 7.33% |
| Q1 2020 Q2Q % growth | 0.25 109.92% | -0.18 | 0.43 | 236.17% |
| Q4 2019 Q2Q % growth | -1.54 47.62% | -1.62 | 0.08 | 5.04% |
| Q3 2019 Q2Q % growth | -1.47 56.25% | -1.76 | 0.29 | 16.53% |
| Q2 2019 Q2Q % growth | -1.80 63.27% | -2.80 | 1.00 | 35.69% |
| Q1 2019 Q2Q % growth | -2.52 50.00% | -3.23 | 0.71 | 21.92% |
| Q4 2018 Q2Q % growth | -2.94 | -3.10 | 0.16 | 5.12% |
| Q3 2018 Q2Q % growth | -3.36 | -4.44 | 1.08 | 24.28% |
| Q2 2018 Q2Q % growth | -4.90 | -4.69 | -0.21 | -4.38% |
| Q1 2018 Q2Q % growth | -5.04 | -5.18 | 0.14 | 2.66% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2024 Q2Q % growth | 235K | 20.4K | 214.6K | 1,051.96% |
| Q4 2023 Q2Q % growth | -100.00% | 53.04K | -53.04K | -100.00% |
| Q3 2023 Q2Q % growth | 353K | 1.53M | -1.177M | -76.93% |
| Q2 2023 Q2Q % growth | 534.776K | -534.776K | -100.00% | |
| Q1 2023 Q2Q % growth | 309.397K | -309.397K | -100.00% | |
| Q4 2022 Q2Q % growth | 10.39M | 218.576K | 10.171M | 4,653.50% |
| Q3 2022 Q2Q % growth | 339.997K | -339.997K | -100.00% | |
| Q2 2022 Q2Q % growth | 2.04M | -2.04M | -100.00% | |
| Q1 2022 Q2Q % growth | 170.003K | -170.003K | -100.00% | |
| Q4 2021 Q2Q % growth | -100.00% | 3.08M | -3.08M | -100.00% |
| Q3 2021 Q2Q % growth | -100.00% | 233.141K | -233.141K | -100.00% |
| Q2 2021 Q2Q % growth | -100.00% | 634.236K | -634.236K | -100.00% |
| Q1 2021 Q2Q % growth | -100.00% | 4.064M | -4.064M | -100.00% |
| Q4 2020 Q2Q % growth | 2.05M 1,364.29% | 128.52K | 1.921M | 1,495.08% |
| Q3 2020 Q2Q % growth | 150K -16.67% | 105.397K | 44.603K | 42.32% |
| Q2 2020 Q2Q % growth | 190K 111.11% | 406.98K | -216.98K | -53.31% |
| Q1 2020 Q2Q % growth | 8.07M | 4.487M | 3.583M | 79.85% |
| Q4 2019 Q2Q % growth | 140K | 158.783K | -18.783K | -11.83% |
| Q3 2019 Q2Q % growth | 180K | 61.2K | 118.8K | 194.12% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -6.98% | 2.81% | -7.44% |
| Revenue | 0% | N/A | -84.63% | -95.35% |